{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:13:45Z","timestamp":1760235225794,"version":"build-2065373602"},"reference-count":40,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1099381"],"award-info":[{"award-number":["1099381"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>We recently characterised the NUP98-HOXD13 (NHD13) mouse as a model of T-cell pre-leukaemia, featuring thymocytes that can engraft in recipient animals and progress to T-cell acute lymphoblastic leukaemia (T-ALL). However, loss of this engraftment ability by deletion of Lyl1 did not result in any loss of leukemogenesis activity. In the present study, we observe that NHD13 thymocytes overexpress EPHA3, and we characterise thymocyte behaviour in NHD13 mice with deletion of EphA3, which show a markedly reduced incidence of T-ALL. Deletion of EphA3 from the NHD13 mice does not prevent the abnormal accumulation or transplantation ability of these thymocytes. However, upon transplantation, these cells are unable to block the normal progression of recipient wild type (WT) progenitor cells through the normal developmental pathway. This is in contrast to the EphA3+\/+\u00a0NHD13 thymocytes, which block the progression of incoming WT progenitors past the DN1 stage. Therefore, EphA3 is not critical for classical self-renewal, but is essential for mediating an interaction between the abnormally self-renewing cells and healthy progenitors\u2014an interaction that results in a failure of the healthy cells to differentiate normally. We speculate that this may orchestrate a loss of healthy cell competition, which in itself has been demonstrated to be oncogenic, and that this may explain the decrease in T-ALL incidence in the absence of EphA3. We suggest that pre-leukaemic self-renewal in this model is a complex interplay of cell-intrinsic and -extrinsic factors, and that multiple redundant pathways to leukaemogenesis are active.<\/jats:p>","DOI":"10.3390\/cancers13153858","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T21:51:07Z","timestamp":1627854667000},"page":"3858","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease Progression"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0581-740X","authenticated-orcid":false,"given":"Adriana C.","family":"Pliego Zamora","sequence":"first","affiliation":[{"name":"The University of Queensland Diamantina Institute, The University of Queensland, Brisbane 4102, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansini","family":"Ranasinghe","sequence":"additional","affiliation":[{"name":"The University of Queensland Diamantina Institute, The University of Queensland, Brisbane 4102, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica E.","family":"Lisle","sequence":"additional","affiliation":[{"name":"The University of Queensland Diamantina Institute, The University of Queensland, Brisbane 4102, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Ki","family":"Ng","sequence":"additional","affiliation":[{"name":"The University of Queensland Diamantina Institute, The University of Queensland, Brisbane 4102, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Huang","sequence":"additional","affiliation":[{"name":"The University of Queensland Diamantina Institute, The University of Queensland, Brisbane 4102, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Racheal","family":"Wadlow","sequence":"additional","affiliation":[{"name":"The University of Queensland Diamantina Institute, The University of Queensland, Brisbane 4102, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Scott","sequence":"additional","affiliation":[{"name":"Olivia Newton-John Cancer Research Institute and La Trobe University, Heidelberg 3084, Australia"},{"name":"Faculty of Medicine, University of Melbourne, Melbourne 3000, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W.","family":"Boyd","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Queensland, Brisbane 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-3092","authenticated-orcid":false,"given":"Christopher I.","family":"Slape","sequence":"additional","affiliation":[{"name":"The University of Queensland Diamantina Institute, The University of Queensland, Brisbane 4102, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.2008.07314.x","article-title":"Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia","volume":"143","author":"Pieters","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2007-02-074690","article-title":"NOTCH1 mutation can be an early, prenatal genetic event in T-ALL","volume":"111","author":"Eguchi","year":"2008","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41375-018-0361-0","article-title":"The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2\/Lyl1","volume":"33","author":"Shields","year":"2019","journal-title":"Leukemia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1182378","article-title":"The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal","volume":"327","author":"McCormack","year":"2010","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.4049\/jimmunol.0901121","article-title":"A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement","volume":"183","author":"Choi","year":"2009","journal-title":"J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2004-12-4794","article-title":"NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrm.2015.16","article-title":"Mechanisms of ephrin-Eph signalling in development, physiology and disease","volume":"17","author":"Kania","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1242\/dev.126.10.2033","article-title":"Eph receptors and ephrins: Effectors of morphogenesis","volume":"126","author":"Holder","year":"1999","journal-title":"Development"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Anderton, M., van der Meulen, E., Blumenthal, M.J., and Schafer, G. (2021). The role of the Eph receptor family in tumorigenesis. Cancers, 13.","DOI":"10.3390\/cancers13020206"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1158\/0008-5472.CAN-20-3047","article-title":"Eph receptors in the immunosuppressive tumor environment","volume":"81","author":"Janes","year":"2021","journal-title":"Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.semcdb.2011.10.014","article-title":"Clinical relevance of Ephs and ephrins in cancer: Lessons from breast, colorectal, and lung cancer profiling","volume":"23","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_15","first-page":"305","article-title":"Normal epithelial cells trigger EphA2-dependent RasV12 cell repulsion at the single cell level","volume":"10","author":"Hill","year":"2019","journal-title":"Small GTPases"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/S0021-9258(19)50725-6","article-title":"Isolation and characterization of a novel receptor-type protein tyrosine kinase (hek) from a human pre-B cell line","volume":"267","author":"Boyd","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood.V94.7.2477.419k13_2477_2486","article-title":"Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells","volume":"94","author":"Dottori","year":"1999","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3816\/CLML.2011.n.006","article-title":"Copy number variations of EphA3 are associated with multiple types of hematologic malignancies","volume":"11","author":"Guan","year":"2011","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/08977194.2014.984808","article-title":"A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activity","volume":"32","author":"Tomasevic","year":"2014","journal-title":"Growth Factors"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.stem.2012.05.024","article-title":"Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells","volume":"11","author":"Ashton","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2013.01.007","article-title":"EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme","volume":"23","author":"Day","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2014.05.001","article-title":"Eph receptor tyrosine kinases in cancer stem cells","volume":"26","author":"Chen","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Janes, P.W., Vail, M.E., Gan, H.K., and Scott, A.M. (2020). Antibody Targeting of Eph Receptors in Cancer. Pharmaceuticals, 13.","DOI":"10.3390\/ph13050088"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/neuonc\/noz175.022","article-title":"Preliminary Findings of a Phase I Safety and Bioimaging Trial of Kb004 (Ifabotuzumab) in Patients with Glioblastoma","volume":"21","author":"Gan","year":"2019","journal-title":"Neuro Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Offenhauser, C., Al-Ejeh, F., Puttick, S., Ensbey, K.S., Bruce, Z.C., Jamieson, P.R., Smith, F.M., Stringer, B.W., Carrington, B., and Fuchs, A.V. (2018). EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma. Cancers, 10.","DOI":"10.3390\/cancers10120519"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"34298","DOI":"10.18632\/oncotarget.16100","article-title":"Epha3 acts as proangiogenic factor in multiple myeloma","volume":"8","author":"Caivano","year":"2017","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/leu.2016.371","article-title":"EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia","volume":"31","author":"Charmsaz","year":"2017","journal-title":"Leukemia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.leukres.2016.09.012","article-title":"KB004, a first in class monoclonal antibody targeting the receptor kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study","volume":"50","author":"Swords","year":"2016","journal-title":"Leuk. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8092","DOI":"10.1128\/MCB.23.22.8092-8098.2003","article-title":"EphA3 null mutants do not demonstrate motor axon guidance defects","volume":"23","author":"Vaidya","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-61779-527-5_3","article-title":"Flow cytometry analysis of cell cycling and proliferation in mouse hematopoietic stem and progenitor cells","volume":"844","author":"Barbier","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/08977194.2014.982276","article-title":"EphA3 biology and cancer","volume":"32","author":"Janes","year":"2014","journal-title":"Growth Factors"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ncb3299","article-title":"A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors","volume":"18","author":"Buono","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/1074-7613(95)90116-7","article-title":"Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo","volume":"3","author":"Rodewald","year":"1995","journal-title":"Immunity"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yexcr.2003.08.021","article-title":"EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion","volume":"292","author":"Smith","year":"2004","journal-title":"Exp. Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/leu.2014.292","article-title":"Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice","volume":"29","author":"Shields","year":"2015","journal-title":"Leukemia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4049\/jimmunol.1801373","article-title":"T Cell Acute Lymphoblastic Leukemia as a Consequence of Thymus Autonomy","volume":"202","author":"Silva","year":"2019","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nature13317","article-title":"Cell competition is a tumour suppressor mechanism in the thymus","volume":"509","author":"Martins","year":"2014","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20120846","article-title":"Thymus-autonomous T cell development in the absence of progenitor import","volume":"209","author":"Martins","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1084\/jem.20120845","article-title":"Thymocytes may persist and differentiate without any input from bone marrow progenitors","volume":"209","author":"Peaudecerf","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1158\/1078-0432.CCR-09-0473","article-title":"Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer","volume":"15","author":"Brannan","year":"2009","journal-title":"Clin. Cancer Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/15\/3858\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:38:06Z","timestamp":1760164686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/15\/3858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,31]]},"references-count":40,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["cancers13153858"],"URL":"https:\/\/doi.org\/10.3390\/cancers13153858","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2021,7,31]]}}}